- Ongoing, recruitingHuman Pharmacology (Phase I)- Other
C4671052- A Phase 1, Randomized, Fixed Sequence, Multiple-Dose, Open-Label Study to Estimate the Effect of Nirmatrelvir (PF-07321332)/Ritonavir on Rosuvastatin Pharmacokinetics in Healthy Adult Participants
This study looks at how a COVID-19 medicine (Nirmatrelvir/Ritonavir) affects a common cholesterol-lowering drug (rosuvastatin, also known as Crestor) in healthy adults. It helps us understand if these medicines can be safely taken together.
For: coronavirus disease 2019 (COVID-19)Belgium - RecruitingPHASE3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
This study is looking at a medicine called nirmatrelvir/ritonavir for children and young people under 18 with COVID-19. It aims to see how safe and effective it is for those who aren't in hospital but are at higher risk of getting seriously ill.
For: COVID-19United States · Bulgaria · Japan